Vensana Capital℠ is a venture capital and growth equity investment firm dedicated to partnering with entrepreneurs who seek to transform healthcare with breakthrough innovations in medical technology.
Vensana was launched in 2019 by Justin Klein and Kirk Nielsen with the support of Versant Ventures. Vensana is actively investing in clinical development and commercial stage companies across the medtech sector, including medical devices, diagnostics and data science, drug delivery, digital health, and tech-enabled services.
We expect to commit our $225 million inaugural fund to a dozen such companies, with typical investments in the range of $10-30 million.
We believe innovation in medtech is accelerating and presents one the most powerful ways we can both improve the quality of healthcare and reduce its cost in the U.S. and around the world.
We seek to partner with entrepreneurs who share our vision and who expect us to contribute more to their mission than just our capital.
Medtech innovation is our passion
Singularly focused on the medtech sector.
Diagnostics & Data Science
Digital Health And Tech-Enabled Services
We share a commitment to our firm’s values and strive to live these values in every aspect of our partnership with our entrepreneurs, our limited partners, our co-investors, and each other.
Mindful of the importance of our work to our companies, clinicians, patients, and our limited partners and their beneficiaries
Integrity, transparency, intellectual honesty, follow-through
Genuine spirit of collaboration across our investment team and with our entrepreneurs and limited partners
Highest standards for ourselves, our companies, and our partners
Fully dedicated to supporting our entrepreneurs who are transforming healthcare